Asset Details
Do you wish to reserve the book?
Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung cancer
Do you wish to request the book?
Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung cancer
2020
Overview
[...]patients undergoing SABR have a worse OS even when adjusting for identifiable confounders and restricting analysis to those aged under 80 years and with PS of 0–1. [...]the median difference between the date of diagnosis and the date of treatment for surgery was 17 days, while that for SABR was 73 days. [...]in order to match patients, these large cohorts are reduced to a subset of those initially analysed for the final comparison. [...]it is likely that the patient population eligible for surgery will expand, giving frailer patients more treatment options.
Publisher
BMJ Publishing Group Ltd and British Thoracic Society,BMJ Publishing Group LTD
